Featured awards of Taslim Al-Hilal
This Featured Award page displays a list that summarizes all grant awards received by an investigator and processed by R&I.
EARLY DETECTION AND GENETIC EVALUATION OF HISPANIC OVARIAN CANCER PATIENTS
Start Date: 3-1-2023
End Date: 10-31-2023
Sponsor: LIZANELL AND COLBERT COLDWELL FOUNDATION
THE ROLE OF TUMOR ENDOTHELIUM-SPECIFIC PRION-LIKE PROTEIN DOPPEL (PRND) GENE IN EPITHELIAL OVARIAN CANCER
Start Date: 9-1-2022
End Date: 8-31-2024
Sponsor: NIH - NATIONAL CANCER INSTITUTE
R01: TARGETING OF DOPPEL-AXIS TO CONTROL LUNG TUMOR ANGIOGENESIS AND IMMUNITY
Start Date: 8-1-2022
End Date: 7-31-2027
Sponsor: NIH - NATIONAL CANCER INSTITUTE
PRIMING PANCREATIC DUCTAL ADENOCARCINOMA USING BLOOD THINNERS TO SENSITIZE THE EFFICACY OF CHECKPOINT IMMUNOTHERAPY
Start Date: 7-5-2022
End Date: 5-31-2026
Sponsor: NIH - NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES
EARLY DETECTION AND THERAPEUTIC TARGETING OF OVARIAN CANCER USING A TESTIS-SPECIFIC PROTEIN DOPPEL
Start Date: 3-3-2022
End Date: 11-30-2022
Sponsor: LIZANELL AND COLBERT COLDWELL FOUNDATION
SELECTIVE LASER SINTERING OF ADDITIVE MANUFACTURING COMPONENTS
Start Date: 3-1-2022
End Date: 8-31-2022
Sponsor: U.S DEPARTMENT OF ENERGY THROUGH HONEYWELL FEDERAL MANUFACTURING & TECHNOLOGY, LLC
ROLE OF MATERNAL E-CIG USE IN EMBRYONIC TO POSTNATAL STAGES OF BRAIN ANGIOGENESIS IN OFFSPRINGS
Start Date: 9-1-2021
End Date: 2-29-2024
Sponsor: NATIONAL INSTITUTES OF HEALTH (NIH) THROUGH NATIONAL INSTITUTE ON MINORITY HEALTH AND HEALTH DISPARITIES
UTEP/UTMDACC PARTNERSHIP FOR HISPANIC CANCER DISPARITIES RESEARCH
Start Date: 8-31-2021
End Date: 8-30-2026
Sponsor: CANCER PREVENTION AND RESEARCH INSTITUTE OF TEXAS
STTR I: RAPID AND REPROGRAMMABLE ASSAY DEVELOPMENT FOR MULTIPLEXED GENE DETECTION
Start Date: 4-12-2021
End Date: 10-11-2021
Sponsor: GINER, INC.
DESIGN AND DEVELOPMENT OF AN EFFICIENT MICROFLUIDIC DEVICE FOR THE DETECTION OF BLOOD CIRCULATING ENDOTHELIAL CELLS (CECS) AS A PAH DIAGNOSTIC MARKER AND TO IDENTIFY AGE-SPECIFIC PAH MEDIATORS
Start Date: 10-1-2019
End Date: 9-30-2021
Sponsor: CARDIOVASCULAR MEDICAL RESEARCH & EDUCATION FUND
EARLY DETECTION AND GENETIC EVALUATION OF HISPANIC OVARIAN CANCER PATIENTS
Start Date: 3-1-2023
End Date: 10-31-2023
Sponsor: LIZANELL AND COLBERT COLDWELL FOUNDATION
THE ROLE OF TUMOR ENDOTHELIUM-SPECIFIC PRION-LIKE PROTEIN DOPPEL (PRND) GENE IN EPITHELIAL OVARIAN CANCER
Start Date: 9-1-2022
End Date: 8-31-2024
Sponsor: NIH - NATIONAL CANCER INSTITUTE
R01: TARGETING OF DOPPEL-AXIS TO CONTROL LUNG TUMOR ANGIOGENESIS AND IMMUNITY
Start Date: 8-1-2022
End Date: 7-31-2027
Sponsor: NIH - NATIONAL CANCER INSTITUTE
PRIMING PANCREATIC DUCTAL ADENOCARCINOMA USING BLOOD THINNERS TO SENSITIZE THE EFFICACY OF CHECKPOINT IMMUNOTHERAPY
Start Date: 7-5-2022
End Date: 5-31-2026
Sponsor: NIH - NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES
EARLY DETECTION AND THERAPEUTIC TARGETING OF OVARIAN CANCER USING A TESTIS-SPECIFIC PROTEIN DOPPEL
Start Date: 3-3-2022
End Date: 11-30-2022
Sponsor: LIZANELL AND COLBERT COLDWELL FOUNDATION
SELECTIVE LASER SINTERING OF ADDITIVE MANUFACTURING COMPONENTS
Start Date: 3-1-2022
End Date: 8-31-2022
Sponsor: U.S DEPARTMENT OF ENERGY THROUGH HONEYWELL FEDERAL MANUFACTURING & TECHNOLOGY, LLC
ROLE OF MATERNAL E-CIG USE IN EMBRYONIC TO POSTNATAL STAGES OF BRAIN ANGIOGENESIS IN OFFSPRINGS
Start Date: 9-1-2021
End Date: 2-29-2024
Sponsor: NATIONAL INSTITUTES OF HEALTH (NIH) THROUGH NATIONAL INSTITUTE ON MINORITY HEALTH AND HEALTH DISPARITIES
UTEP/UTMDACC PARTNERSHIP FOR HISPANIC CANCER DISPARITIES RESEARCH
Start Date: 8-31-2021
End Date: 8-30-2026
Sponsor: CANCER PREVENTION AND RESEARCH INSTITUTE OF TEXAS
STTR I: RAPID AND REPROGRAMMABLE ASSAY DEVELOPMENT FOR MULTIPLEXED GENE DETECTION
Start Date: 4-12-2021
End Date: 10-11-2021
Sponsor: GINER, INC.
DESIGN AND DEVELOPMENT OF AN EFFICIENT MICROFLUIDIC DEVICE FOR THE DETECTION OF BLOOD CIRCULATING ENDOTHELIAL CELLS (CECS) AS A PAH DIAGNOSTIC MARKER AND TO IDENTIFY AGE-SPECIFIC PAH MEDIATORS
Start Date: 10-1-2019
End Date: 9-30-2021
Sponsor: CARDIOVASCULAR MEDICAL RESEARCH & EDUCATION FUND
